Cann Group eyes S3 product and the end of ‘unsophisticated’ formulations by Steve Jones February 18, 2021February 25, 2021 In the first of a two-part interview with Cannabiz, Cann Group chief operating officer Shane Duncan […]
Drop SAS for CBD prescriptions, GP urges, as industry calls for low dose re-think by Steve Jones November 5, 2020November 5, 2020
Warning over CBD ‘red herring’ amid concerns about TGA demands by Steve Jones July 15, 2020August 5, 2020